Dileep Damodaran

10PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
ERAS Compliance and Postoperative Outcome in Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

|Apr 27, 2026
Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis.

|Feb 05, 2026
Patient Preference for Non-operative Treatment Strategy in Locally Advanced Rectal Cancers: A Cross-sectional Survey.

Vishnukumar Tumma, K S Vishnu, Syam Vikram

|Feb 05, 2026
An Audit of 1000 Breast Cancer Cases with Molecular Subtype Analysis from a Tertiary Care Cancer Centre in India.

Dayananda R, Syam Vikram, Deepak Damodaran

|Mar 21, 2025
Moulding Breasts, Shaping Lives: Propagating Oncoplastic Surgery.

Gokul R Krishnan, Syam Vikram, Deepak Damodaran

|May 06, 2024
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study.

Aditi Bhatt, Snita Sinukumar, Dileep Damodaran

Pageof 2

Frequent Collaborators

4 joint publications

Snita Sinukumar

4 joint publications

Aditi Bhatt

2 joint publications

Mukurdipi Ray

2 joint publications

Ninad Katdare